Does Amlodipine Increase Cancer Incidence? | Zendy

Larry B. Goldstein | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Does Amlodipine Increase Cancer Incidence?

Author(s) -

Larry B. Goldstein

Publication year - 2001

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.104.2.e5

Subject(s) - amlodipine , medicine , randomized controlled trial , incidence (geometry) , cancer , placebo , cardiology , blood pressure , physics , alternative medicine , pathology , optics

To the Editor:The Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT)1 amplifies the controversy over calcium antagonists and increased cancer risk.2 In this 36-month, placebo-controlled, randomized trial, the calcium antagonist amlodipine had no effect on the angiographic progression of coronary atherosclerosis or on the risk of major cardiovascular events. In the group assigned to amlodipine, the annualized rates of coronary …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research